Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
BCC016: Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
Badgett, James
(PI)
Pediatrics
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Medulloblastoma
100%
Eflornithine
100%
Polyamine
33%
Anabolism
16%
Ornithine Decarboxylase
16%
Hedgehog Signaling Pathway
16%
Intracranial Tumor
16%
Pediatrics
16%
Biosynthesis
16%